{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"bioRxiv"}],"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T05:53:44Z","timestamp":1782280424721,"version":"3.54.5"},"posted":{"date-parts":[[2025,7,30]]},"group-title":"Microbiology","reference-count":41,"publisher":"openRxiv","license":[{"start":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T00:00:00Z","timestamp":1753833600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.biorxiv.org\/about\/FAQ#license"}],"funder":[{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"crossref","award":["R01GM140154"],"award-info":[{"award-number":["R01GM140154"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"crossref","award":["T32AI007419"],"award-info":[{"award-number":["T32AI007419"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"crossref","award":["U19AI17129201"],"award-info":[{"award-number":["U19AI17129201"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2025,7,30]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                <jats:p>Emerging viruses pose an ongoing threat to human health. While certain viral families are common sources of outbreaks, predicting the specific virus within a family that will cause the next outbreak or pandemic is not possible, creating an urgent need for broad spectrum antiviral drugs that are effective against an array of related viral pathogens. However, broad spectrum drug development is hindered by the lack of detailed knowledge of compound binding sites that are structurally and functionally conserved between viral family members and are essential for virus replication. To overcome this limitation, we developed an in silico approach that combines AI-driven protein structure prediction, computational fragment soaking, multiple sequence alignment, and protein stability calculations to identify highly conserved target sites that are both solvent-accessible and conserved. We applied this approach to the Togaviridae family, which includes emerging pandemic disease threats such as chikungunya and Venezuelan equine encephalitis virus for which there are currently no approved antiviral therapies. Our analysis identified multiple solvent accessible and structurally conserved pockets in the alphavirus non-structural protein 2 (nsP2) protease domain, which is essential for processing of the viral replicase proteins. Mutagenesis of key solvent accessible and conserved residues identified novel pockets that are essential for protease activity and the replication of multiple alphaviruses, validating these pockets as potential antiviral target sites for nsP2 inhibitors. These findings highlight the potential of artificial intelligence-informed modeling for revealing functionally conserved, accessible pockets as a means of identifying potential target binding sites for broadly active direct acting antivirals.<\/jats:p>\n                <jats:sec>\n                  <jats:title>Significance Statement<\/jats:title>\n                  <jats:p>Here we present a novel integrative computational approach to identify novel target sites for broadly acting antiviral drugs. We used this technique to identify multiple functionally and structurally conserved protein surface pockets within the alphavirus nsP2 protease and methyl-transferase-like domain. Mutagenesis of these pockets identified that they are essential for protease activity and replication of a genetically diverse group of alphaviruses, validating these sites as potential targets for broadly active small molecule alphavirus inhibitors. This integrative AI-driven approach thus provides an important tool in developing antivirals essential for pandemic preparedness.<\/jats:p>\n                <\/jats:sec>","DOI":"10.1101\/2025.07.30.667737","type":"posted-content","created":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T04:35:14Z","timestamp":1753936514000},"source":"Crossref","is-referenced-by-count":1,"title":["Novel Computational Pipeline to Identify Target Sites for Broad Spectrum Antiviral Drugs"],"prefix":"10.64898","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4713-2241","authenticated-orcid":false,"given":"John D.","family":"Sears","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantin I.","family":"Popov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Sylvester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebekah","family":"Dickmander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Loome-Diaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Che-Kang","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Huff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wes","family":"Sanders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas A.","family":"Saba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madeleine","family":"Sorensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam M.","family":"Drobish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas A.","family":"May","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Namitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Fecko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie J.","family":"Arnold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neela H.","family":"Yennawar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig E.","family":"Cameron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas E.","family":"Morrison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Tropsha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark T.","family":"Heise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathaniel J.","family":"Moorman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"54368","reference":[{"key":"2025080109450437000_2025.07.30.667737v1.1","first-page":"174","article-title":"SARS-CoV-2, SARS-CoV, and MERS-COV: A comparative overview","volume":"28","year":"2020","journal-title":"Infez. Med"},{"key":"2025080109450437000_2025.07.30.667737v1.2","doi-asserted-by":"publisher","DOI":"10.1007\/s00705-020-04628-0"},{"key":"2025080109450437000_2025.07.30.667737v1.3","doi-asserted-by":"publisher","DOI":"10.1038\/nrd703"},{"key":"2025080109450437000_2025.07.30.667737v1.4","doi-asserted-by":"crossref","first-page":"e3002187","DOI":"10.1371\/journal.pbio.3002187","article-title":"Structural biology: A golden era","volume":"21","year":"2023","journal-title":"PLoS Biol"},{"key":"2025080109450437000_2025.07.30.667737v1.5","doi-asserted-by":"publisher","DOI":"10.1038\/S41586-021-03819-2"},{"key":"2025080109450437000_2025.07.30.667737v1.6","doi-asserted-by":"publisher","DOI":"10.1038\/S41586-024-07487-W"},{"key":"2025080109450437000_2025.07.30.667737v1.7","doi-asserted-by":"publisher","DOI":"10.1126\/science.abj8754"},{"key":"2025080109450437000_2025.07.30.667737v1.8","doi-asserted-by":"crossref","unstructured":"V. Lulla , et al., Timeliness of proteolytic events is prerequisite for efficient functioning of the alphaviral replicase. J. Virol. 92 (2018).","DOI":"10.1128\/JVI.00151-18"},{"key":"2025080109450437000_2025.07.30.667737v1.9","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.63.11.4653-4664.1989"},{"key":"2025080109450437000_2025.07.30.667737v1.10","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.67.4.1916-1926.1993"},{"key":"2025080109450437000_2025.07.30.667737v1.11","doi-asserted-by":"crossref","unstructured":"E. M. Merten , et al., Identification of a cell-active chikungunya virus nsP2 protease inhibitor using a covalent fragment-based screening approach. Proc. Natl. Acad. Sci. USA 121 (2024).","DOI":"10.1073\/pnas.2409166121"},{"key":"2025080109450437000_2025.07.30.667737v1.12","doi-asserted-by":"crossref","first-page":"5786","DOI":"10.1021\/acsomega.0c06191","article-title":"1,3-Thiazolbenzamide Derivatives as Chikungunya Virus nsP2 Protease Inhibitors","volume":"6","year":"2021","journal-title":"ACS Omega"},{"key":"2025080109450437000_2025.07.30.667737v1.13","doi-asserted-by":"crossref","unstructured":"D. S. Metibemu , et al., Inhibitor of the non-structural protein 2 protease shows promising efficacy in mouse models of chikungunya. Eur. J. Med. Chem. 278, 116808 (2024).","DOI":"10.1016\/j.ejmech.2024.116808"},{"key":"2025080109450437000_2025.07.30.667737v1.14","doi-asserted-by":"publisher","DOI":"10.1101\/2025.06.30.662352"},{"key":"2025080109450437000_2025.07.30.667737v1.15","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.4c01346"},{"key":"2025080109450437000_2025.07.30.667737v1.16","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-91673-x"},{"key":"2025080109450437000_2025.07.30.667737v1.17","doi-asserted-by":"publisher","DOI":"10.1016\/j.str.2006.07.010"},{"key":"2025080109450437000_2025.07.30.667737v1.18","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1210418109"},{"key":"2025080109450437000_2025.07.30.667737v1.19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2018.05.007"},{"key":"2025080109450437000_2025.07.30.667737v1.20","doi-asserted-by":"crossref","unstructured":"F. Sievers , et al., Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega. Mol. Syst. Biol. 7, 539 (2011).","DOI":"10.1038\/msb.2011.75"},{"key":"2025080109450437000_2025.07.30.667737v1.21","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btp036"},{"key":"2025080109450437000_2025.07.30.667737v1.22","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1101835108"},{"key":"2025080109450437000_2025.07.30.667737v1.23","doi-asserted-by":"crossref","unstructured":"F. Engelberger , J. D. Zakary , G. K\u00fcnze , Guiding protein design choices by per-residue energy breakdown analysis with an interactive web application. Front. Mol. Biosci. 10, 1178035 (2023).","DOI":"10.3389\/fmolb.2023.1178035"},{"key":"2025080109450437000_2025.07.30.667737v1.24","doi-asserted-by":"publisher","DOI":"10.1016\/0264-410X(86)90003-4"},{"key":"2025080109450437000_2025.07.30.667737v1.25","doi-asserted-by":"publisher","DOI":"10.1016\/0042-6822(92)90268-T"},{"key":"2025080109450437000_2025.07.30.667737v1.26","doi-asserted-by":"publisher","DOI":"10.1016\/j.febslet.2006.01.071"},{"key":"2025080109450437000_2025.07.30.667737v1.27","doi-asserted-by":"crossref","unstructured":"K. Rausalu , et al., Chikungunya virus infectivity, RNA replication and non-structural polyprotein processing depend on the nsP2 protease\u2019s active site cysteine residue. Sci. Rep. 6, 37124 (2016).","DOI":"10.1038\/srep37124"},{"key":"2025080109450437000_2025.07.30.667737v1.28","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02921-15"},{"key":"2025080109450437000_2025.07.30.667737v1.29","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmgm.2010.04.005"},{"key":"2025080109450437000_2025.07.30.667737v1.30","doi-asserted-by":"crossref","unstructured":"G. Hoffka , et al., Self-inhibited State of Venezuelan Equine Encephalitis Virus (VEEV) nsP2 Cysteine Protease: A Crystallographic and Molecular Dynamics Analysis. J. Mol. Biol. 435, 168012 (2023).","DOI":"10.1016\/j.jmb.2023.168012"},{"key":"2025080109450437000_2025.07.30.667737v1.31","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-52061-7"},{"key":"2025080109450437000_2025.07.30.667737v1.32","doi-asserted-by":"publisher","DOI":"10.1038\/s41596-021-00659-2"},{"key":"2025080109450437000_2025.07.30.667737v1.33","doi-asserted-by":"publisher","DOI":"10.1517\/17460441.2010.484460"},{"key":"2025080109450437000_2025.07.30.667737v1.34","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gku316"},{"key":"2025080109450437000_2025.07.30.667737v1.35","doi-asserted-by":"publisher","DOI":"10.1038\/nprot.2015.043"},{"key":"2025080109450437000_2025.07.30.667737v1.36","doi-asserted-by":"crossref","unstructured":"36. T. H. Jukes , C. R. Cantor , \u201cEvolution of protein molecules\u201d in Mammalian Protein Metabolism, (Elsevier, 1969), pp. 21\u2013132.","DOI":"10.1016\/B978-1-4832-3211-9.50009-7"},{"key":"2025080109450437000_2025.07.30.667737v1.37","doi-asserted-by":"crossref","unstructured":"G.-Y. Yu , et al., Complete coding sequences of eastern equine encephalitis virus and venezuelan equine encephalitis virus strains isolated from human cases. Genome Announc. 3 (2015).","DOI":"10.1128\/genomeA.00243-15"},{"key":"2025080109450437000_2025.07.30.667737v1.38","doi-asserted-by":"crossref","unstructured":"K. S. Carpentier , et al., Discrete viral E2 lysine residues and scavenger receptor MARCO are required for clearance of circulating alphaviruses. eLife 8 (2019).","DOI":"10.7554\/eLife.49163"},{"key":"2025080109450437000_2025.07.30.667737v1.39","doi-asserted-by":"crossref","unstructured":"J. Diaz , et al., U-CAN-seq: A Universal Competition Assay by Nanopore Sequencing. Viruses 16 (2024).","DOI":"10.3390\/v16040636"},{"key":"2025080109450437000_2025.07.30.667737v1.40","doi-asserted-by":"publisher","DOI":"10.1038\/nmeth.2019"},{"key":"2025080109450437000_2025.07.30.667737v1.41","doi-asserted-by":"crossref","unstructured":"M. T. Heise , et al., An attenuating mutation in nsP1 of the Sindbis-group virus S.A.AR86 accelerates nonstructural protein processing and up-regulates viral 26S RNA synthesis. J. Virol. 77, 1149\u20131156 (2003).","DOI":"10.1128\/JVI.77.2.1149-1156.2003"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1101\/2025.07.30.667737","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T05:01:41Z","timestamp":1782277301000},"score":1,"resource":{"primary":{"URL":"http:\/\/biorxiv.org\/lookup\/doi\/10.1101\/2025.07.30.667737"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,30]]},"references-count":41,"URL":"https:\/\/doi.org\/10.1101\/2025.07.30.667737","relation":{"is-preprint-of":[{"id-type":"doi","id":"10.1016\/j.antiviral.2025.106322","asserted-by":"subject"}]},"subject":[],"published":{"date-parts":[[2025,7,30]]},"subtype":"preprint"}}